Jin Medical International (ZJYL) Stock Price, News & Analysis

Company Overview

Jin Medical International Co., Inc. (NASDAQ: ZJYL) is a U.S.-listed healthcare company specializing in elective medical services and aesthetic surgery. Through its network of affiliated hospitals and clinics, the company offers a range of cosmetic and reconstructive procedures, including plastic surgery, dermatology treatments, dental aesthetics, anti‐aging therapies and ophthalmic care. Its facilities serve both domestic and international patients, with primary operations located in key Chinese cities and strategic partnerships across Asia Pacific.

Founded in 2013 and headquartered in Miami, Jin Medical International has expanded its footprint by acquiring and integrating specialty hospitals and outpatient clinics. These include leading plastic surgery centers in Shijiazhuang and Kunming, which have been developed into comprehensive medical beauty hubs. The company leverages digital platforms for appointment management and telemedicine consultations, enhancing patient access to pre- and post-operative care. In addition to clinical services, Jin Medical International provides professional training programs for its medical staff, drawing on expertise from international advisory members.

Over the years, Jin Medical’s growth strategy has focused on combining Western medical protocols with traditional Chinese aesthetic philosophies. The leadership team is composed of healthcare industry veterans, including Dr. Qiang Li, Chief Executive Officer, and Ms. Yanfang Xu, Chief Financial Officer, supported by an international board of medical advisors. This governance structure underpins the company’s commitment to high standards of patient safety, quality outcomes and innovation in aesthetic medicine.

Looking ahead, Jin Medical International aims to strengthen its regional market share through continued investment in technology, expanded service offerings and selective partnerships. By integrating advanced imaging systems, AI-assisted diagnostics and minimally invasive techniques, the company seeks to enhance treatment precision and patient satisfaction while pursuing opportunities in emerging markets across Southeast Asia.

Key Stats

• Today's Range: $0.59 to $0.65
• 50-Day Range: $0.58 to $0.90
• 52-Week Range: $0.50 to $4.38
• Volume: 269,735 shs
• Average Volume: 286,721 shs
• Market Capitalization: $100.19 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ZJYL Stock Analysis - Frequently Asked Questions

How have ZJYL shares performed this year?

Jin Medical International's stock was trading at $0.7782 on January 1st, 2025. Since then, ZJYL stock has decreased by 17.8% and is now trading at $0.64.

When did Jin Medical International IPO?

Jin Medical International (ZJYL) raised $8 million in an IPO on Tuesday, March 28th 2023. The company issued 1,000,000 shares at a price of $8.00 per share.

How do I buy shares of Jin Medical International?

Shares of ZJYL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Jin Medical International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Jin Medical International investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE).

Company Calendar

• Today: 7/12/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:ZJYL
• CIK: 1837821
• Web: www.zhjmedical.com
• Phone: 86-519-8960-7972
• Fax: N/A
• Employees: 245
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $23.50 million
• Price / Sales: 4.26
• Cash Flow: $0.03 per share
• Price / Cash Flow: 24.05
• Book Value: $0.18 per share
• Price / Book: 3.56

Miscellaneous

• Outstanding Shares: 156,550,000
• Free Float: N/A
• Market Cap: $100.19 million
• Optionable: Not Optionable
• Beta: 9.85